|
|
|
|
|
|
|
|
|
|
Rv1908c More about Rv1908c on TBDB.org More about Rv1908c on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv1908c: Codons 320 to 339: 18 mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Chan RCY JAC 2007 | TGG/CGG | 961 | 321 | Trp/Arg | 1994-2004 | Hong Kong | PCR-SSCP, Sequencing | Whole gene | N.S. | - | Absolute concentration method | 250 | 241 | 3 | - |
| Bostanabad SZ Tuberk Torak 2007 | TGG/TAG | 961 | 321 | Trp/STOP | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 2/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Bostanabad SZ Tuberk Torak 2007 | TGG/TTG | 962 | 321 | Trp/Leu | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 2/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Bostanabad SZ Tuberk Torak 2007 | TGG/TCC | 962-963 | 321 | Trp/Ser | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 1/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Bostanabad SZ Tuberk Torak 2007 | TGG/TGT | 963 | 321 | Trp/Cys | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 1/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| No publication listed | ACC/CCC | 970 | 324 | Thr/Pro | - | - | - | - | - | - | - | - | - | - | - |
| Musser JM JID 1996 | TGG/GGG | 982 | 328 | Trp/Gly | 1996 | - | Sequencing | Whole gene | HR | >=1ug/ml for I | Proportion method | 34/46 | 1/0 | - | - |
| Haas WA AAC 1997 | TGG/TTG | 983 | 328 | Trp/Leu | 1997 | Free state, Lesotho, Eastern Cape, Natal, Swaziland, Gauteng | PCR-RFLP | 894 bp central fragment of katG | H | - | - | 124/212 | 1/0 | - | - |
| Boonaiam S CMI 2009 | TGG/TCG | 984 | 328 | Trp/Ser | 2005-2006 | Thailand | Sequencing | Whole gene | MDR | >=1ug/ml for I | Disk elution method | 160/170 | 1/0 | - | - |
| Haas WA AAC 1997 | TGG/TGC | 984 | 328 | Trp/Cys | 1997 | Free state, Lesotho, Eastern Cape, Natal, Swaziland, Gauteng | PCR-RFLP | 894 bp central fragment of katG | H | - | - | 124/212 | 1/0 | - | - |
| Bostanabad SZ Tuberk Torak 2007 | TGG/TGT | 984 | 328 | Trp/Cys | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 4/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Zenteno-Cuevas R MemInstOswaldCruz 2009 | AGT/TGT | 991 | 331 | Ser/Cys | 2007 | Mexico | Sequencing | codon 240-390 of katG | HRS | N.S. | BACTEC 460 | 17/25 | 1/0 | katG S315T | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | - | See Note | 334 | Ile/Thr Error | - | - | - | - | - | - | - | - | - | - | - |
| Rouse DA AAC 1995 | ATC/ACC | 1004 | 335 | Ile/Thr | - | - | - | - | - | - | - | - | - | - | - |
| Lipin MY CMI 2007 | ATC/GTC | 1003 | 335 | Ile/Val | 1998-2001 | Russia | Sequencing | nt 872-1568 | HRS | 1 ug/ml I, 5 ug/ml S, 20ug/ml R | Absolute concentration method | 217/217 | 1/0 | 315 AGC/AGA katG | - |
| Lee ASG AAC 1999 | CTG/CGG | 1007 | 336 | Leu/Arg | - | - | - | - | - | - | - | - | - | - | - |
| Cockerill FR JID 1995 | TAC/TTC | 1010 | 337 | Tyr/Phe | 1995 | USA | PCR, RFLP, Sequencing. | Whole gene | H | 0.25ug/ml | Proportion method | - | - | Pro2Ser, Ala65Thr, Ala66Pro, Met126Ile, Ala243Ser, Asn258Ser, Ala264Thr | - |
| Cockerill FR JID 1995 | TAC/TGC | 1010 | 337 | Tyr/Cys | 1995 | USA | PCR, RFLP, Sequencing. | Whole gene | H | 1ug/ml | Proportion method | - | 1/0 | Arg429Leu, Trp505Arg, Met609Ile | - |
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |